InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: Tzr250rg post# 738

Monday, 12/06/2021 2:11:25 PM

Monday, December 06, 2021 2:11:25 PM

Post# of 811
VYNE Therapeutics assumed with a Buy at H.C. Wainwright 06:09 VYNE H.C. Wainwright analyst Joseph Pantginis assumed coverage of VYNE Therapeutics with a Buy rating and $7 price target. The company's "reinvigorated" pipeline of assets is focused on developing novel therapies for inflammatory indications, Pantginis tells investors in a research note.

Read more at:
https://thefly.com/n.php?id=3421371
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYNE News